Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01116921 · ClinicalTrials.gov registry record · NA
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT01116921 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 103 participants.
The verdict
NCT01116921, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
The primary objective of this research is to compare the need for intubation and mechanical ventilation in the first seven days of life for infants with respiratory distress syndrome (RDS) on nasal continuous positive airway pressure (nCPAP) who receive surfactant via a Laryngeal Mask Airway (LMA) with those who are maintained on nCPAP and do not receive surfactant.
Interventions
- DEVICE Nasal continuous positive airway pressure (nCPAP)
- DEVICE Laryngeal Mask Airway (LMA) to deliver surfactant
- DRUG Surfactants, Pulmonary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01116921
The ClinicalTrials.gov registry entry for NCT01116921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nasal continuous positive airway pressure (nCPAP) is the first listed.
NCT01116921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01116921 about?
NCT01116921 is a clinical study titled "Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates". The primary objective of this research is to compare the need for intubation and mechanical ventilation in the first seven days of life for infants with respiratory distress syndrome (RDS) on nasal continuous positive airway pressure (nCPAP) who receive surfactant via a Laryngeal Mask Airway (LMA) w...
What is the current status of trial NCT01116921?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2011-02. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01116921?
The interventions under investigation include: Nasal continuous positive airway pressure (nCPAP) (DEVICE), Laryngeal Mask Airway (LMA) to deliver surfactant (DEVICE), Surfactants, Pulmonary (DRUG).
Who is sponsoring clinical trial NCT01116921?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.